Characterization of pseudotype VSV possessing HCV envelope proteins

Virology

Volumn 286, Issue 2, 2001, Pages 263-275

  Matsuura, Yoshiharu ^a,b   Tani, Hideki ^a   Suzuki, Kensuke ^c   Kimura Someya, Tomomi ^b   Suzuki, Ryosuke ^b   Aizaki, Hideki ^b   Ishii, Koji ^b   Moriishi, Kohji ^a   Robison, Clinton S ^d   Whitt, Michael A ^d   Miyamura, Tatsuo ^b  

^a OSAKA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c JAPAN TOBACCO INC   (Japan)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Envelope proteins; Hepatitis C virus; Infection; Pseudotype virus

Indexed keywords

CELL SURFACE PROTEIN; GLYCOSAMINOGLYCAN; GREEN FLUORESCENT PROTEIN; HEPARIN LYASE; LACTOFERRIN; PERIODATE SODIUM; PHOSPHOLIPASE C; PRONASE; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; CHIMERA; CONTROLLED STUDY; GENE EXPRESSION; HEPATITIS C; HEPATITIS C VIRUS; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REPORTER GENE; VESICULAR STOMATITIS VIRUS; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS RECOMBINANT; VIRUS TYPING;

BOVINAE; HEPATITIS C VIRUS; VESICULAR STOMATITIS VIRUS;

EID: 0035422262     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2001.0971     Document Type: Article

References (66)

1. Full-length complementary DNA of hepatitis C virus genome from an infectious blood sample
2. The natural history of community-acquired hepatitis C in the United States
3. Binding of Sindbis virus to cell surface heparan sulfate
4. Molecular modeling of protein-glycosaminoglycan interactions
5. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate
6. Vaccination of chimpanzees against infection by the hepatitis C virus
7. The transmembrane domain of hepatitis C virus glycoprotein E1 is a signal for static retention in the endoplasmic reticulum
8. A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2
9. Formation of native hepatitis C virus glycoprotein complexes
10. Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses
11. Folding, assembly, and subcellular localization of hepatitis C virus glycoproteins
12. Glycosylation of the hepatitis C virus envelope protein E1 is dependent on the presence of a downstream sequence on the viral polyprotein
13. Lack of protective immunity against reinfection with hepatitis C virus
14. Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein
15. A heterologous heparin-binding domain can promote functional attachment of a pseudorabies virus gC mutant to cell surfaces
16. Processing of the E1 glycoprotein of hepatitis C virus expressed in mammalian cells
17. Suramin blocks hepatitis C binding to human hepatoma cells in vitro
18. Expression and identification of hepatitis C virus polyprotein cleavage products
19. Hepatitis C viruses
20. Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes
21. Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells
22. High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C
23. Cultivation of hepatitis C virus in primary hepatocyte culture from patients with chronic hepatitis C results in release of high titre infectious virus
24. Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate
25. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus
26. Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor
27. Fusion-competent vaccines: Broad neutralization of primary isolates of HIV
28. Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus
29. Recombinant vesicular stomatitis viruses from DNA
30. Vaccines to prevent viral hepatitis
31. CD81 (TAPA-1): A molecule involved in signal transduction and cell adhesion in the immune system
32. Binding of herpes simplex virus to cellular heparan sulphate, an initial step in the adsorption process
33. Processing of E1 and E2 glycoproteins of hepatitis C virus expressed in mammalian and insect cells
34. Highly stable expression of a foreign gene from rabies virus vectors
35. Analysis of the glycosylation sites of hepatitis C virus (HCV) glycoprotein E1 and the influence of E1 glycans on the formation of the HCV glycoprotein complex
36. Functional features of hepatitis C virus glycoproteins for pseudotype virus entry into mammalian cells
37. Characterization of hepatitis C virus replication in cloned cells obtained from a human T-cell leukemia virus type 1-infected cell line, MT-2
38. Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans
39. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family
40. Efficient selection for high-expression transfectants with a novel eukaryotic vector
41. Ligand-induced activation of chimeric receptors between the erythropoietin receptor and receptor tyrosine kinases
42. Analysis of the molecules involved in human T-cell leukaemia virus type 1 entry by a vesicular stomatitis virus pseudotype bearing its envelope glycoproteins
43. Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T cell lines
44. Binding of hepatitis C virus to CD81
45. Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses
46. Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41
47. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: Cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells
48. Expression from cloned cDNA of cell-surface secreted forms of the glycoprotein of vesicular stomatitis virus in eucaryotic cells
49. Microbial adherence to and invasion through proteoglycans
50. Genetic control of cellular susceptibility to pseudotypes of Rous sarcoma virus
51. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma
52. Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles
53. Infectious rabies viruses from cloned cDNA
54. Complex processing and protein: Protein interactions in the E2:NS2 region of HCV
55. Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line
56. A system for functional analysis of Ebola virus glycoprotein
57. Cell fusion activity of hepatitis C virus envelope proteins
58. Virus entry is a major determinant of cell tropism of Edmonston and wild-type strains of measles virus as revealed by vesicular stomatitis virus pseudotypes bearing their envelope proteins
59. Mode of interaction between pseudorabies virus and heparan sulfate/heparin
60. Identification of a putative alphavirus receptor on mouse neural cells
61. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant
62. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: Potential role in chronic HCV infections
63. Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones
64. Adaptation to persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera
65. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate
66. Hepatitis C virus envelope proteins bind lactoferrin